Simulations Plus, Inc. (SLP)

NASDAQ: SLP · Real-Time Price · USD
20.46
+0.11 (0.54%)
At close: Dec 4, 2025, 4:00 PM EST
20.78
+0.29 (1.42%)
Pre-market: Dec 5, 2025, 4:00 AM EST
0.54%
Market Cap412.16M
Revenue (ttm)79.18M
Net Income (ttm)-64.72M
Shares Out 20.14M
EPS (ttm)-3.22
PE Ration/a
Forward PE38.42
Dividendn/a
Ex-Dividend Daten/a
Volume390,488
Open20.41
Previous Close20.35
Day's Range20.17 - 20.77
52-Week Range12.39 - 37.67
Beta1.17
AnalystsBuy
Price Target26.80 (+30.99%)
Earnings DateJan 6, 2026

About SLP

Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through Software and Services segments. The company offers GastroPlus, which predicts absorption, biopharmaceutics, pharmacokinetics, and pharmacodynamics in humans and animals; and DDDPlus and MembranePlus simulation products. It also provides products based on mechanistic and mathematical models, such as DILIsym... [Read more]

Sector Healthcare
IPO Date Jun 18, 1997
Employees 213
Stock Exchange NASDAQ
Ticker Symbol SLP
Full Company Profile

Financial Performance

Financial Statements

Analyst Summary

According to 7 analysts, the average rating for SLP stock is "Buy." The 12-month stock price target is $26.8, which is an increase of 30.99% from the latest price.

Price Target
$26.8
(30.99% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Why Shares of Simulations Plus Soared This Week

Shares of Simulations Plus had gained more than 20% as of midday Thursday. The company reported mixed results, but its guidance calls for revenue and earnings growth in fiscal 2026 despite a difficult...

18 hours ago - The Motley Fool

Simulations Plus: Buying On Long-Term Silico Drug-Development

Simulations Plus is a specialized in silico software-and-services platform. They help with model-informed, non-animal drug development. SLP's services help across discovery, development, and clinical ...

2 days ago - Seeking Alpha

Why Simulations Plus Stock Was Soaring Today

Its full-year fiscal 2025 featured a double-digit revenue increase. As for the fourth quarter, its performance was mixed.

2 days ago - The Motley Fool

Simulations Plus Stock Climbs On Earnings Strength, Biotech Market Rebound

Simulations Plus Inc. (NASDAQ: SLP) shares climbed on Tuesday after the company reported better-than-expected fourth-quarter 2025 earnings and reaffirmed annual guidance.

2 days ago - Benzinga

Simulations Plus, Inc. (SLP) Q4 2025 Earnings Call Transcript

Simulations Plus, Inc. (SLP) Q4 2025 Earnings Call Transcript

3 days ago - Seeking Alpha

Simulations Plus Reports Fourth Quarter and Fiscal 2025 Financial Results

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus” or the “Company”), a global leader in cheminformatics, biosimulation, clinical operations soluti...

3 days ago - Business Wire

SIMULATIONS PLUS INVESTIGATION: Bragar Eagel & Squire, P.C. Urges Simulations Plus Investors to Contact the Firm Regarding Their Rights

Bragar Eagel & Squire, P.C.  Litigation Partner  Brandon Walker  Encourages Investors Who Suffered Losses In Simulations Plus (SLP) To Contact Him Directly To Discuss Their Options If you purchased or...

4 weeks ago - GlobeNewsWire

SLP INVESTORS: Simulations Plus, Inc. Hit with Securities Fraud Investigation after Stock Plummets 26% -- Investors Urged to Contact BFA Law

NEW YORK, Oct. 24, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Simulations Plus, Inc. (NASDAQ: SLP) for potential violations of the ...

5 weeks ago - GlobeNewsWire

Simulations Plus Announces Preliminary Fiscal Year 2025 Results and Fiscal Year 2026 Guidance

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus” or the “Company”), a leading provider of cheminformatics, biosimulation, simulation-enabled perf...

6 weeks ago - Business Wire

SLP STOCK NOTICE: Simulations Plus, Inc. Investors with Losses may have been Affected by Securities Fraud – Contact BFA Law about its Pending Investigation

NEW YORK, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm  Bleichmar Fonti & Auld LLP announces an investigation into Simulations Plus, Inc. (NASDAQ: SLP) for potential violations of the...

6 weeks ago - GlobeNewsWire

SLP SECURITIES NEWS: Simulations Plus, Inc. Faces a Securities Fraud Investigation after Stock Drops 26% -- Contact BFA Law if You Suffered Losses

NEW YORK, Oct. 20, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Simulations Plus, Inc. (NASDAQ: SLP) for potential violations of the ...

6 weeks ago - GlobeNewsWire

SLP SECURITIES NOTICE: Simulations Plus, Inc. Securities Fraud Investigation is Pending – Contact BFA Law if You Lost Money

NEW YORK, Oct. 10, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Simulations Plus, Inc. (NASDAQ: SLP) for potential violations of the ...

7 weeks ago - GlobeNewsWire

SLP FRAUD NOTICE: Simulations Plus, Inc. Hit with Securities Fraud Investigation Due to Impairment Charges -- Contact BFA Law if You Suffered Losses

NEW YORK, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Simulations Plus, Inc. (NASDAQ: SLP) for potential violations of the ...

2 months ago - GlobeNewsWire

SLP SHAREHOLDER NOTICE: Simulations Plus, Inc. Investigated for Securities Fraud after 26% Stock Drop – Contact BFA Law

NEW YORK, Oct. 06, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm  Bleichmar Fonti & Auld LLP announces an investigation into Simulations Plus, Inc. (NASDAQ: SLP) for potential violations of the...

2 months ago - GlobeNewsWire

Johnson Fistel Investigates Simulations Plus Following Reports of Financial and Internal Control Issues

SAN DIEGO, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP announces that it is investigating potential claims on behalf of investors of Simulations Plus, Inc. (NASDAQ: SLP) regarding possible ...

2 months ago - GlobeNewsWire

Simulations Plus (SLP) Faces Investor Scrutiny After Asset Impairment and Auditor Firing-- Hagens Berman

SAN FRANCISCO, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Hagens Berman has launched an investigation into Simulations Plus, Inc. (NASDAQ: SLP) after the company's stock price plummeted approximately 25% on J...

2 months ago - GlobeNewsWire

SLP SECURITIES NEWS: Why did Simulations Plus, Inc. Stock Drop 26%? Investors with Losses Reminded to Contact BFA Law

NEW YORK, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Simulations Plus, Inc. (NASDAQ: SLP) for potential violations of the...

2 months ago - GlobeNewsWire

The Bottom Fishing Club - Simulations Plus: Huge Potential In AI Drug Discovery

Simulations Plus appears to be a unique Buy candidate, driven by an ultra-low valuation and the potential for AI-inspired growth in drug discovery modeling. The FDA Modernization Act 2.0 and industry ...

2 months ago - Seeking Alpha

SLP SECURITIES NOTICE: Did Simulations Plus, Inc. Mislead Investors? Contact BFA Law if You Lost Money on Your Investment

NEW YORK, Sept. 12, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Simulations Plus, Inc. (NASDAQ: SLP) for potential violations of the...

2 months ago - GlobeNewsWire

Simulations Plus, Inc. (SLP) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)

Simulations Plus, Inc. (NASDAQ:SLP) Morgan Stanley 23rd Annual Global Healthcare Conference September 10, 2025 2:35 PM EDT Company Participants Shawn O'Connor - Chief Executive Officer Presentation U...

3 months ago - Seeking Alpha

SLP FRAUD NOTICE: Simulations Plus, Inc. Hit with Securities Fraud Investigation after 26% Stock Drop – Investors Urged to Contact BFA Law

NEW YORK, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Simulations Plus, Inc. (NASDAQ: SLP) for potential violations of the...

3 months ago - GlobeNewsWire

SLP SHAREHOLDERS: Simulations Plus, Inc. Investors may have been Affected by Fraud – Contact BFA Law if You Lost Money (NASDAQ:SLP)

NEW YORK, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Simulations Plus, Inc. (NASDAQ: SLP) for potential violations of the ...

3 months ago - GlobeNewsWire

Simulations Plus to Participate in Upcoming Investor Conferences

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”, “SLP”), a leading provider of cheminformatics, biosimulation, simulation-enabled performance an...

3 months ago - Business Wire

SLP INVESTOR NOTIFICATION: Simulations Plus, Inc. Investors are Urged to Contact BFA Law about the Pending Securities Fraud Investigation (NASDAQ:SLP)

NEW YORK, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Simulations Plus, Inc. (NASDAQ: SLP) for potential violations of the ...

3 months ago - GlobeNewsWire

Simulations Plus (SLP) Faces Investor Scrutiny After Asset Impairments and Grant Thornton Contests Company Statements About Dismissal -- Hagens Berman

SAN FRANCISCO, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Investors in Simulations Plus, Inc. (NASDAQ: SLP) saw the price of their shares decline about 25% on July 15, 2025 after the company reported its Q3 20...

3 months ago - GlobeNewsWire